Keurig Dr Pepper Inc. (NASDAQ: KDP) — A Crown-Jewel Soda Franchise Shackled to a Fading Coffee Empire, Now Splitting Itself in Two

⚡ Claude’s Take

This block is the author’s own independent opinion and general information, not investment advice. The analysis that follows it is deliberately position-free and carries no price target.

Verdict: HOLD / own-for-the-income-and-the-catalyst / accumulate-on-weakness below ~$26–27 / not-a-short. Fair-value zone ~$28–34 today (≈14–16x legacy adj. EPS ~$2.05, or the middle of a $22.50–35.90 sum-of-the-parts), widening toward the mid-$30s if the 2027 split re-rates the beverage business. Conviction: medium.

KDP is the rare consumer staple that is cheap against its own decade of history (AZI own-history percentiles: composite 36.6th, P/E 46.7th, P/B 36.8th, P/S 26.2nd) — the mirror image of the KO/PEP/MNST/GWW “richest-ever” cohort that has filled this coverage book. At $30.76 it trades ~12x trailing EV/EBITDA and ~15x forward earnings while carrying a genuinely elite asset — Dr Pepper, the brand that quietly passed Pepsi to become the #2 single carbonated-soft-drink trademark in America, inside a 28%-margin, share-gaining U.S. beverage segment. The catch is what’s bolted to it: a structurally eroding single-serve coffee business (Keurig pods, patents expired, profit down three straight years) that management has just doubled down on — buying Dutch coffee giant JDE Peet’s for ~$22.5B (~12.9x EBITDA), levering net debt from ~$15B to ~$31B (~4.5x), and bringing in a $4.5B senior convertible preferred — expressly so it can split the whole thing into two pure-plays by early 2027. The market is right to discount the leverage, the coffee drag, and a brand-new C-suite running the most complex transaction in company history; it is arguably wrong to price the whole enterprise for ~2% perpetual growth when the crown-jewel half compounds mid-single-digits with real pricing power.

This is a value / special-situation, not a momentum trade and — after a +24% bounce off the $24.87 October-2025 trough — no longer a falling knife. Factor-wise it is exactly what it looks like: a low-beta (~0.18–0.46), DividendYield/LowVol/Staples name with no momentum loading and five years of dead money behind it. The problem is that my own sum-of-the-parts says the conglomerate discount is modest-to-absent — at $30.76 the equity already sits near the middle of the $22.50–35.90 SOTP band, so you are paid a ~3% dividend to wait for a split whose value is largely in the price. That is a HOLD, not a fat pitch. The asymmetry turns genuinely attractive only on weakness toward the high-$20s/mid-$20s, where you’d be buying Dr Pepper for a song and getting the coffee optionality free. Flips bullish if the separation completes cleanly and Beverage Co. lists at a KO/PEP-adjacent multiple while leverage falls a half-turn a year. Flips bearish if coffee margins keep sliding, the split slips or is abandoned, and ~4.5x leverage meets a soda-volume air-pocket from GLP-1/health pressure — leaving a financially-engineered, over-levered conglomerate with a senior preferred ahead of you. Tag: “the cheapest way to own Dr Pepper — bundled with a coffee business it’s trying to divorce.”

📈 Stock Price Action — Five-Year Event Map

KDP has been dead money for half a decade. The split-adjusted shares round-tripped from ~$27.5 (Jan-2021) up to an all-time high of $36.15 (Aug-2022), then spent 2023–24 grinding sideways in a $30–33 band before a deal-driven slide to a five-year low of $24.87 (Oct-2025) and a sharp +24% recovery to $30.76 (6/18/2026). The five-year annualized total price return is essentially zero; the stock sits ~15% below its 2022 high, mid-way up a 52-week range of $24.87–$34.30, and just above its rising 200-day EMA (~$28.7). The price move is FACT; the attributed cause in each row is INTERPRETATION.

Narrative: (1) KDP worked early — the 2018 Keurig/Dr Pepper Snapple merger looked validated as the combined company pushed price through 2021–22 inflation and investors paid up for defensives, taking the stock to its 2022 peak. (2–3) Then the rate cycle and a self-inflicted cash-flow scare (operating cash flow collapsed to $1.33B in FY23 as the controversial accounts-payable/supplier-finance stretch reversed) capped the multiple, and 2024 added GLP-1/soda anxiety plus a $718M non-cash impairment that optically halved GAAP EPS. (4–5) The decisive leg down was self-imposed: on 25-Aug-2025 management announced it would buy JDE Peet’s and split the company — doubling leverage to chase coffee scale right before spinning it off — and the stock fell ~11% that day and kept sliding to $24.87 as a coffee-cost squeeze and JAB’s relentless selldown weighed. (6–7) The recovery since is a value/catalyst trade: the deal closed on schedule (1-Apr-2026), guidance held, and the final clearing of the long JAB overhang (full exit, 11-Jun-2026) plus a fresh Bernstein “Outperform” pulled the shares back to $30.76.

Executive Summary

Keurig Dr Pepper is two very different businesses wearing one ticker. The first — U.S. Refreshment Beverages (63% of FY25 sales, $10.4B, a 28.2% operating margin and rising) — is a genuinely high-quality franchise built on Dr Pepper, a brand whose unique flavor profile KO and PEP have never replicated and which has gained CSD share for two decades, surrounded by a fast-growing energy/hydration portfolio (GHOST, C4, Bloom, Black Rifle, Electrolit) that KDP feeds through an owned direct-store-delivery (DSD) network. The second — U.S. Coffee (24%, $4.0B, 24.1% margin and falling) — is the Keurig single-serve system, a razor/blade model whose moat expired with its pod patents; segment operating income has declined three straight years and fell 21% in Q1-2026 on a green-coffee cost squeeze. International (13%) rounds out a company that is ~82% U.S. and #3 behind Coca-Cola and PepsiCo.

Management’s answer to this bifurcation is radical: in August 2025 it agreed to acquire Dutch coffee giant JDE Peet’s for ~$22.5B EV (~12.9x EBITDA), closed it on 1 April 2026, and announced it will split KDP into two separately-listed companies — “Beverage Co.” (Dr Pepper/CSD/energy) and “Global Coffee Co.” (Keurig + JDE Peet’s) — with operational readiness targeted for end-2026 and the legal separation in early 2027. This effectively unwinds the 2018 merger that created KDP — a tacit admission that coffee-plus-soda never delivered the promised synergy. The financial cost is steep: net debt roughly doubles from ~$15B to ~$31B (~4.5x), and the structure now includes a $4.5B 4.75% convertible perpetual preferred (Apollo) that sits senior to common, plus a $4B minority interest in a coffee-pod manufacturing JV.

The economics underneath are better than the GAAP headline. Consolidated ROIC of ~6.9% is a goodwill artifact — $44B of goodwill and brand intangibles from the 2018 deal bury a business whose cash/tangible return on capital exceeds 40%. Underlying (adjusted) EPS compounds at a steady mid-to-high-single-digit rate; the volatile GAAP line ($0.94→$1.52→$1.01→$1.56→$1.06→$1.53 over 2020–25) is driven almost entirely by below-the-line mark-to-market on equity stakes and episodic impairments, not operations. Free cash flow is real but lumpy (~$1.5–2.0B steady-state), and the 2022–23 cash-flow whipsaw from a payables-stretch program is a quality-of-earnings demerit worth remembering.

Valuation is the whole debate. KDP is the cheapest of the beverage majors on its own history and against peers (~12x EV/EBITDA, ~15x forward P/E, ~3% yield), and a reverse-DCF says the current ~$53–57B EV embeds only ~2% perpetual growth — pricing a demonstrated ~7% revenue compounder for near-stagnation. That is the bull case. The bear case is in our own sum-of-the-parts: valuing Beverage Co. at a deserved premium and Coffee Co. at a deserved discount yields equity of roughly $22.50–35.90/share, and at $30.76 the stock already sits near the middle of that band. The conglomerate discount is modest, not gaping; the upside is a levered option on the split re-rating the beverage half, the downside is ~4.5x leverage, a senior preferred ahead of common, and a fading coffee business meeting a GLP-1-pressured soda category. The body that follows takes no position; it lays out the evidence on both sides.

1. Business Overview

Keurig Dr Pepper was created in July 2018 when JAB Holdings’ Keurig Green Mountain (single-serve coffee) merged, via reverse-morphosis, with publicly-traded Dr Pepper Snapple Group (CSDs and non-cola beverages). The combined company is the third-largest beverage company in North America by revenue behind Coca-Cola and PepsiCo, headquartered in Burlington, Massachusetts and Frisco, Texas. As of FY2025 it generated $16.6B in net sales at a 54.2% gross margin, 22.0% operating margin, and $2.08B in net income, with roughly 82% of revenue from the United States. It employs ~28,000 people (pre-JDE Peet’s; ~48,000+ pro-forma after adding JDE Peet’s ~20,000).

Segments (FY2025, the new three-segment structure adopted in 2025):

How it makes money. The two halves run fundamentally different models:

• Refreshment Beverages combines an asset-light concentrate/brand business (Dr Pepper, Canada Dry, 7UP, A&W, Sunkist, Squirt, Snapple, Mott’s, Clamato, Core Hydration, Bai, Evian distribution) with an owned DSD distribution network that physically delivers finished beverages to retail. The concentrate piece carries very high incremental margins (KDP sells flavor syrup to bottlers); the DSD piece is the strategic weapon — KDP rents that route-to-market to fast-growing partner brands (GHOST and C4 energy, Bloom prebiotic, Black Rifle, Electrolit hydration, La Colombe RTD coffee), earns distribution margin, then frequently acquires the brand later (it bought a 60% stake in GHOST in 2025; the rest is contracted for ~2028). FACT: management quantified GHOST’s incremental distribution as ~2 points of U.S. Refreshment Beverages growth in Q1-2026. This “incubate-via-DSD-then-acquire” flywheel is a real and somewhat under-appreciated asset.

• U.S. Coffee is a razor/blade system: Keurig brewers (the razor, sold roughly at cost and declining ~high-single-digits per year) drive recurring purchases of K-Cup pods (the blade — Q1-2026 pod sales of ~$840M dwarfed ~$116M of brewer sales). KDP earns on owned brands (Green Mountain, The Original Donut Shop, McCafé licensed) and on licensing/manufacturing pods for partner brands (Starbucks via Nestlé, Lavazza, Dunkin’, Peet’s). The category is mature; the system’s economics are under pressure from compatible/private-label pods and saturating brewer households.

• International is concentrate + finished-goods + coffee across Canada, Mexico, and the Caribbean, dominated by strong local CSD positions (Canada Dry, Crush, Peñafiel/Squirt in Mexico) and pricing-led growth.

Recurring vs. cyclical. The revenue base is overwhelmingly consumable-staple and recurring — soda, water, energy, and coffee pods are bought weekly. The only genuinely discretionary/cyclical line is coffee brewers (durable appliances), which is small and shrinking. Revenue is therefore highly defensive; the variability is in margins (commodity cost cycles — green coffee, aluminum, PET, freight) and in below-the-line items, not in volume.

Verdict: A defensible, mostly-recurring staples revenue base with a clear bifurcation — a growing, high-margin beverage engine and a mature, declining coffee system — about to be physically separated.

2. Industry Dynamics

KDP straddles three industries with very different structures.

U.S. carbonated soft drinks (CSD) — structurally attractive oligopoly. This is one of the better consumer categories in America: a rational three-firm structure (Coca-Cola ~46% volume share, PepsiCo ~26%, KDP ~21%) with high barriers to entry (brand equity built over a century, shelf space, and — decisively — DSD distribution scale that a newcomer cannot economically replicate). Pricing has been consistently rational; the category has pushed multi-year price increases through inflation with manageable elasticity. FACT: in Q1-2026 management noted CSD retail dollars grew mid-single-digits and accelerated from Q4, with positive category volume even after pricing. Within CSD, the standout structural fact is that Dr Pepper passed Pepsi-Cola to become the #2 single CSD trademark by volume in the U.S. (~8–8.5% share, per Beverage Digest, 2023–24) — a remarkable two-decade share-gain story. Profit pools here are deep and stable.

Single-serve coffee — structurally deteriorating (Marathon late/bust phase). The Keurig system pioneered and dominates U.S. single-serve, but the category is in the late stage of its capital cycle. The original K-Cup patents expired years ago; the result is a flood of compatible and private-label pods that arbitrage the installed base KDP built, commoditizing the high-margin “blade.” Brewer households are saturating (unit sales declining ~high-single-digits). Layer on a 2024–26 green-coffee cost super-spike (arabica futures hit multi-decade highs) plus tariffs, and segment profitability has compressed even as the category volume holds. FACT: U.S. Coffee operating income fell from ~$1.16B (2023) toward $962M (2025) and dropped 21% YoY in Q1-2026. Keurig still commands ~73% of pod-maker household purchases, but of a shrinking, lower-margin pool. The JDE Peet’s acquisition extends KDP globally into a similarly mature, commodity-arabica-exposed business — a bigger pond, not a structurally better one.

Energy drinks — fast-growing, but KDP is a late, subscale entrant. The ~$29B U.S. energy category grows mid-teens with long runway (channel expansion, household penetration, female-forward cohorts). KDP has assembled a >$1B portfolio (GHOST, C4, Bloom, Black Rifle) via DSD and acquisition — credible and growing share — but it is a follower behind Monster (~30% share) and Celsius/Red Bull, and its position is partly acquired rather than organically built.

Structural headwinds. GLP-1 anti-obesity drugs are a slow, real volume headwind for sugary soda (some estimates put a meaningful share of food-and-beverage units under GLP-1 influence by 2030); KDP’s growing zero-sugar mix and energy/hydration exposure partly offset this. Regulatory/tax pressure (Mexico’s beverage tax hit International volume in Q1-2026; U.S. SNAP soda-eligibility waivers are a watch item) is a persistent low-grade negative.

Verdict: Bifurcated. U.S. CSD is a genuinely good, oligopolistic, pricing-rational industry; single-serve coffee is a structurally deteriorating one in the bust phase of its capital cycle; energy is good but KDP is subscale there. Net: a good beverage business sitting in a mediocre-and-worsening coffee one — which is precisely the logic of the split.

3. Competitive Position

The honest answer is that KDP has one strong moat and one eroding one, and naming the mechanism for each (Greenwald taxonomy) matters more than a blended verdict.

Dr Pepper / CSD — a genuine brand-intangible + scale-distribution moat. Dr Pepper’s competitive advantage is the rarest kind: a non-replicable product identity (its 23-flavor profile is something neither Coca-Cola nor Pepsi has successfully cloned — tellingly, in some markets Coca-Cola itself distributes Dr Pepper rather than competes with a copycat) reinforced by distribution scale (the DSD network) and habit captivity (consumers reach for the same flavor reflexively). This passes the two Greenwald tests cleanly: the market-share-stability test — Dr Pepper has gained share for ~20 years, the signature of a real barrier — and the ROIC test at the segment/cash level (a 28.2% operating margin with pricing power that consistently offsets inflation). The energy portfolio adds a distribution-scale advantage (DSD is hard to replicate) but weaker brand captivity (energy consumers are more promiscuous, and KDP’s brands are challengers, not leaders).

Keurig / coffee — an eroding installed-base moat. Keurig’s advantage was a classic razor/blade installed-base lock-in protected by pod patents. With the patents gone, the moat is the textbook “in the long run, every product becomes a toaster”: the installed base persists, but the captivity that monetized it has been arbitraged away by compatible pods and private label. The share-stability test now points the wrong way — segment income declining three years running — and the ROIC test is deteriorating (margin from ~26% toward ~24% and falling). This is a fading, not a durable, moat. JDE Peet’s brings strong brands (L’OR, Jacobs, Douwe Egberts, Peet’s, Tassimo, Senseo) but in a commodity-input, regionally-competed global coffee market where scale helps sourcing but does not confer pricing power over Nestlé.

Direct comparison vs. KO and PEP. Both are clearly stronger than KDP: global reach (KDP is ~82% U.S.; Dr Pepper’s trademark abroad is often owned by others, a hard ceiling on international expansion), broader and deeper brand portfolios, and superior scale. KDP is the structurally-disadvantaged #3 — but its flagship brand out-executes Pepsi’s flagship cola, and its DSD-incubation model gives it a credible, differentiated growth engine in emerging beverage white space that the giants partly cede. Against Monster/Celsius in energy, KDP is a portfolio challenger, not a leader.

Verdict: A bifurcated moat — a durable, share-gaining beverage franchise (real, brand-intangible + distribution-scale advantage) welded to a structurally eroding coffee one. The split is the rational response: separate the franchise worth a premium multiple from the business that deserves a discount. The consolidated ~6.9% ROIC dramatically understates the beverage moat (it is a 2018-merger goodwill artifact); the cash/tangible return on the operating assets is north of 40%.

4. Growth History and Forward Opportunities

History. Revenue compounded from $11.6B (2020) to $16.6B (2025), a ~7.4% CAGR — strong for a staples company, and notably resilient: KDP grew through the inflation surge on pricing and kept volume positive where many peers traded volume for price. The mix of drivers has been healthy — a blend of net price realization, organic volume/mix (Dr Pepper share gains, zero-sugar, energy), and distribution/bolt-on additions (GHOST, C4, Electrolit, Bloom). FY2025 net sales rose 8.1%; Q1-2026 rose 8.1% (net price +5.5, volume/mix +2.6).

By segment, recently: U.S. Refreshment Beverages is the outsized growth engine — Q1-2026 net sales +11.9% with operating income +9.8%, led by CSD share gains, a >$1B-and-growing energy portfolio, and sports hydration (Electrolit). U.S. Coffee is the drag — Q1-2026 sales −2.3% (pods −7% on trade-inventory destocking, brewers −high-single-digits on elasticity) with operating income −21% on the green-coffee cost squeeze. International grew +8.5% constant-currency on pricing but with soft volume (Mexico beverage tax) and a −15% operating-income quarter on cost.

Forward opportunities (the credible ones):

• CSD innovation & white space: Canada Dry Fruit Splash, Dr Pepper Creamy Coconut (the “dirty soda” trend), Dr Pepper Zero Sugar (growing double-digits), Bloom Pop prebiotic CSDs.
• Energy ramp: continued share gains and distribution/PDP expansion for GHOST and Bloom in a mid-teens-growth category; >$1B portfolio with runway.
• Coffee self-help: the next-gen Keurig Alta system (DTC launch planned late 2026, spanning Keurig, premium Peet’s, and partner brands), the Keurig Coffee Collective premium innovation, and the renewed/expanded Nestlé–Starbucks K-Cup agreement. Whether these reverse the structural pod commoditization is the open question.
• JDE Peet’s synergies & global coffee scale: ~$400M targeted cost synergies plus North American Peet’s/Keurig revenue cross-sell — the value-creation case for the coffee combination.
• Post-split optionality: management argues Beverage Co. as a standalone can pursue route-to-market optimization, earlier-stage brand partnerships, and new geographies more aggressively.

Quality of growth. The beverage growth is high-quality (organic, share-gaining, pricing-backed, high-margin). The coffee growth is low-quality and currently negative (commodity-squeezed, destocking, structural pod pressure). The acquired growth (JDE Peet’s) buys scale but at a full price in a low-growth category. FY2026 total-company guidance is net sales $25.9–26.4B (legacy KDP +4–6% cc plus an $8.5–8.7B JDE Peet’s stub) and low-double-digit EPS growth — but ~6–7 points of that EPS growth is simply the JDE Peet’s acquisition, with only 4–6% from the legacy base.

Verdict: Mixed-quality growth. Genuinely high-quality, durable expansion in beverages; structurally challenged, commodity-whipsawed coffee; and a large, fully-priced acquisition that flatters headline growth without proving it. The beverage half is the growth story worth owning.

5. Financial Quality

This section is where skepticism earns its keep: KDP’s reported financials require heavy normalization, and the headline GAAP numbers are among the lowest-signal in the staples universe.

Margin structure & operating leverage. Consolidated gross margin runs ~52–56%, operating margin ~22%, EBITDA margin ~26–28% — strong, stable, staples-grade economics. The story is bifurcated underneath: U.S. Refreshment Beverages carries a 28.2% segment margin that is expanding (real operating leverage and pricing power), while U.S. Coffee’s ~24% margin is contracting on green-coffee inflation. Q1-2026 consolidated gross margin contracted 220bps — which management framed as the peak year-over-year decline, improving through 2026 as coffee hedges roll and inflation eases.

Earnings quality — the crux. GAAP EPS has sawtoothed for six years ($0.94 / $1.52 / $1.01 / $1.56 / $1.06 / $1.53) while operating income rose almost every year ($2.5B → $3.65B). The volatility lives entirely below the operating line in two buckets:

1. Non-cash mark-to-market on KDP’s strategic equity stakes (e.g., its former Vita Coco position, bottler/partner investments) — “Other expense/income, net” swung by hundreds of millions year to year (a ~$192M adverse swing in FY25; a prior-year gain on the Vita Coco sale lapped in Q1-2026).
2. Episodic impairments — $718M in FY24 and $489M in FY22 (per the cash-flow statement), which optically depressed those years’ GAAP EPS without touching cash operations.

The correct run-rate is therefore adjusted EPS, which compounds steadily (FY25 ~$2.05; FY26 guided to low-double-digit growth). FACT: stock-based compensation is genuinely small and clean (~$97M, ~0.6% of revenue) — KDP does not manufacture adjusted earnings by excluding large SBC, a favorable contrast to most “adjusted-EPS” companies in this book.

The cash-flow quality demerit. Operating cash flow is not a clean, smooth series, and the reason is a real governance/QoE black mark: in 2020–22 KDP ran an aggressive accounts-payable stretch / supplier-finance program that inflated reported OCF (FY22 AP contributed +$903M to cash flow), then reversed violently in FY23 (AP −$1,618M, collapsing OCF to $1,329M — just 0.61x net income). Reported FCF is thus unreliable as a trend metric; the smoothed steady-state is ~$1.5–2.0B, with FY25 OCF $1.99B and FCF ~$1.5B against rising capex ($379M → $503M as KDP invests in cold-fill and coffee capacity). FACT: management guides FY26 to ~$2.5B aggregate FCF (legacy ~$2B plus 9 months of JDE Peet’s net of deal costs).

Balance sheet. The defining feature is deeply negative tangible common equity (TCE ~−$18.5B; the balance sheet carries ~$44B of goodwill + brand intangibles from the 2018 merger against ~$25.5B of book equity). Pre-deal net debt was $15.1B (~3.4x EBITDA). Post-JDE Peet’s, net debt roughly doubles to ~$31B (~4.5x), with interest expense already up sharply in Q1-2026 ($281M vs. $148M) and guided to ~$1.13–1.16B for FY26. The financing stack adds a $4.5B 4.75% convertible perpetual preferred (Apollo “AP Pour Holdings”) that is senior to common and a $4B coffee-pod-JV minority interest — both dilute common economics and rank ahead of the equity. KDP remains investment-grade and is prioritizing debt paydown (targeting ~0.5x of deleveraging per year), but the margin of safety in the balance sheet is now gone until the split and deleveraging play out.

Returns. Consolidated ROIC is ~6.9% (FY25) — below a reasonable WACC and falling, but this is a goodwill artifact: strip the $44B of acquisition intangibles and the cash/tangible return on the operating assets exceeds 40%, which is the true measure of the underlying business quality. ROE of 30–80% is meaningless here (a thin/levered book). The uncomfortable truth the asset-growth anomaly flags: management keeps levering up to buy growth, so per-share and consolidated returns do not improve even though the operating economics are excellent — JDE Peet’s layers yet more lower-return coffee goodwill on top.

Verdict: Excellent underlying economics, low-signal reported financials, and a balance sheet that has lost its cushion. Do economics improve with scale? At the operating level, modestly yes (beverage operating leverage). At the capital-allocation level, no — the returns are diluted by serial goodwill-heavy M&A. Own the brands; distrust the GAAP line and normalize everything.

6. Capital Allocation

Until 2025, KDP’s capital allocation was unremarkable-but-fine for a staple: a steadily-growing dividend (~3% growth annually, ~$1.00/share, ~60% payout), light opportunistic buybacks, sensible distribution-led bolt-ons (GHOST, C4, La Colombe, Electrolit, Atypique) funded by ~$1.5–2.5B of FCF. The events of 2025–26 change the verdict.

The defining act — JDE Peet’s + the split. On 25 August 2025, KDP agreed to acquire JDE Peet’s (the Reimann/JAB-controlled Dutch coffee giant) for €31.85/share, ~$18.4B equity / ~$22.5B EV, ~12.9x forward EV/EBITDA — a full price (HSBC called it “rich,” downgrading to Hold and cutting its target from $42 to $30) for a slower-growth, commodity-arabica-exposed business with only ~$400M of identified synergies (~1.8% of EV). The deal closed 1 April 2026. Simultaneously, KDP announced it would split into two listed companies — Beverage Co. and Global Coffee Co. — reversing the 2018 logic that combined coffee and soda in the first place. INTERPRETATION: this is a partial admission that the 2018 merger’s “single-serve-plus-CSD” synergy thesis failed; the strategic case for first bulking up coffee at a full price and then handing it to shareholders is a financial-engineering bet that the pure-play multiples will exceed the conglomerate’s — plausible, but a 2026–27 show-me, and one that loads ~$16B of additional debt onto the balance sheet to execute.

A notable related-party wrinkle: the seller, JAB/Acorn, held ~69% of JDE Peet’s — so JAB monetized both sides of the transaction (selling its coffee asset to KDP at a full price) while simultaneously exiting its KDP stake. A sophisticated coffee insider sold its coffee business to KDP and walked away from KDP’s equity in the same window. That is worth weighing heavily.

The JAB overhang — fully cleared (the clean positive). JAB’s KDP stake fell from ~24% (2018) → ~21% (Feb-2024) → ~16.5% (Oct-2024) → ~10.7% (Feb-2025) → ~4.4% (May-2025) → zero via a final ~59M-share (4.3%) block trade on 11 June 2026. This removes a multi-year technical overhang and improves float and governance independence — unambiguously good for the remaining shareholders, even as the reason for selling is a soft negative on the deal.

Financing & leverage. The ~$38B/5.6x peak leverage was managed down to ~$31B/~4.5x by raising the $4.5B Apollo convertible preferred (BevCo) and the $4B coffee-pod-JV minority, plus ~$6B of new senior debt and term loans. Deleveraging via FCF is now the stated #1 priority; buybacks are off the table; the dividend is maintained. Post-split leverage targets are 3.5–4.0x (BevCo) and 3.75–4.25x (Coffee Co).

Compensation & incentives — a Marathon-style size mis-incentive (the governance flaw). The short-term incentive plan weights Net Sales 30% / Adjusted Operating Income 50% / Free Cash Flow 20% — all absolute-size metrics, with no ROIC, no per-share, and (until recently) no relative-TSR component. Performance share units (PSUs) — measuring Net Sales growth and Adjusted Diluted EPS growth — were only added in 2025 after shareholder pressure (25% of LTIP), an improvement but still without a capital-efficiency or relative-TSR gate. A management team that just doubled the balance sheet is, by design, paid to get bigger. Mitigants: heavy mandatory stock ownership (CEO at 9.2x salary), an “Elite Investment Program,” and a recovered say-on-pay vote (~96% in 2026 vs. ~82% in 2023). CEO Tim Cofer’s 2025 total comp was ~$8.2M — modest by mega-cap standards.

Insider tape — no signal. Form 4 activity is entirely routine grant/vest/withhold (codes M/A/F); there are zero open-market purchases (code P) even with the stock ~30% off its highs in late 2025. No insider conviction signal either way.

Leadership turnover. A near-total C-suite refresh around the deal adds execution risk: Tim Cofer became CEO (April 2024, succeeding 2018-architect Bob Gamgort, who departed in 2025); Anthony DiSilvestro joined as CFO (Nov-2025, ex-Mattel/Campbell, age 67 — a transitional/execution hire); Rafael Oliveira (JDE Peet’s CEO) will lead Global Coffee Co.; a new Chief Transformation Officer was added. A new, unproven-together team is running the most complex transaction in company history.

Verdict: Below average / on watch. Ordinary-staple discipline pre-2025, demerited by a full-priced, debt-doubling coffee acquisition with thin synergies, a size-oriented incentive design, and a related-party seller who exited KDP’s equity in the same breath. The split could prove value-creating, and the JAB-overhang clearing is a genuine positive — but management must now earn back credibility through clean execution and deleveraging.

7. Changes and Headwinds — Last Two Years

The last 24 months have been the most consequential in KDP’s history since the 2018 merger:

• JDE Peet’s acquisition (announced Aug-2025, closed 1-Apr-2026): ~$22.5B EV; transforms KDP into a global coffee player and roughly doubles net debt. Weakens the balance sheet; strategically a precursor to the split.
• The planned split (announced Aug-2025; readiness end-2026, separation early-2027): Beverage Co. (Dr Pepper/CSD/energy) and Global Coffee Co. (Keurig + JDE Peet’s). The single biggest swing factor in the thesis — potentially value-unlocking, potentially value-destroying financial engineering.
• JAB’s full exit (completed 11-Jun-2026): clears the multi-year overhang; improves float/governance.
• $4.5B Apollo convertible preferred + $4B coffee-JV minority: new senior claims ahead of common; reduce headline debt but dilute common economics.
• Leadership refresh: new CEO (Cofer, 2024), new CFO (DiSilvestro, 2025), coffee CEO-designate (Oliveira), new transformation office.
• Commodity shock: a 2024–26 green-coffee super-spike plus tariffs squeezed U.S. Coffee margins (−21% IFO in Q1-2026); aluminum/PET/freight inflation (Middle-East-conflict-linked) is hedged for 2026 but a 2027 watch item. Management expects coffee costs to ease in H2-2026 and potentially become a 2027 tailwind.
• Demand headwinds: GLP-1 pressure on sugary soda; Mexico beverage tax; U.S. SNAP soda-eligibility waivers — all manageable so far, none yet thesis-breaking.

Verdict: Net negative for the near-term thesis, with a catalyst embedded. The changes add leverage, complexity, commodity risk, and execution risk faster than they add proven value; the offsets are the cleared JAB overhang and the optionality of a clean 2027 split. The thesis pivots almost entirely on split execution.

8. Risk Analysis (Risk Matrix)

Net: The dominant risks are self-imposed (split execution, leverage, the coffee bet), not existential. This is not a balance sheet at risk of failure; it is a quality franchise temporarily over-levered and mid-restructuring. Catastrophic loss risk is low.

9. Valuation Discussion (embedded expectations)

Where KDP trades. At $30.76 (6/18/2026): ~$42B equity, ~1.36B shares, EV ~$53–57B (YE25 basis; higher pro-forma with JDE Peet’s debt). On legacy FY25: ~12x trailing EV/EBITDA, ~14.5x EV/EBIT, ~15x forward P/E (on FY26 adj. EPS ~$2.05), ~3.0% dividend yield (~60% payout), ~3–4% FCF yield. Crucially, on its own ten-year history KDP is cheap: AZI percentiles read composite 36.6th, P/E 46.7th, P/B 36.8th, P/S 26.2nd — the opposite of the record-rich quality cohort. (Ignore the absolute P/E percentile’s noise given GAAP distortion; the P/S and EV/EBITDA tells are the cleaner read.)

Peer comparison (the cheapest beverage major):

KDP’s discount to KO/MNST is partly justified (US-centricity, #3 position, the coffee drag, deal/leverage overhang) and partly a function of the same complexity that creates the split opportunity. Against a de-rated PEP it is only modestly cheaper.

Sum-of-the-parts (the core argument, given the announced separation). Valuing the two future companies on segment EBITDA × deserved multiples:

• Beverage Co. (U.S. Refreshment + International; ~28%-margin, share-gaining, KO/PEP-adjacent quality): ~$3.5B EBITDA × 13–16x = ~$45.6–56.1B EV.
• Global Coffee Co. (U.S. Coffee + JDE Peet’s; ~$16B sales, lower-growth, commodity-exposed): ~$2.6B EBITDA × 8–11x = ~$20.5–28.2B EV.
• Total SOTP EV ≈ $66–84B, less pro-forma net debt ~$31B and the $4.5B senior preferred → equity ≈ $30.6–48.8B, or ~$22.50–$35.90/share (midpoint ~$29).

The uncomfortable conclusion: at $30.76 (~$41.8B equity) the market already values KDP near the middle of its own SOTP range. The conglomerate discount is modest-to-absent, not gaping. The equity today is a levered option on Beverage Co. re-rating and Coffee Co. not de-rating; meaningful margin of safety appears only below ~$26–27.

Reverse-DCF / embedded expectations. The standalone ~$53–57B EV embeds only ~2% perpetual growth at KDP’s margins and cost of capital — i.e., the market is pricing a demonstrated ~7% revenue compounder for near-stagnation. That is the heart of the bull case: if Beverage Co. simply keeps doing what it has done (mid-single-digit organic, share gains, pricing), the embedded expectation is too low. The bear rebuttal: the leverage, the senior preferred, the coffee structural decline, and the execution risk are exactly why the market underwrites stagnation, and the SOTP says they are largely already in the price.

Verdict: KDP is genuinely cheap on its own history and on a reverse-DCF, but only fairly valued on a sum-of-the-parts. The market is underwriting too little growth for the beverage half and appropriate caution for the coffee half and the leverage. There is no price target here; the embedded-expectations read is “priced for stagnation, worth more if the split delivers, but not a screaming bargain at $30.76.”

10. Variant Perception

Consensus view. KDP is a cheap, slightly-broken staple: a good soda business diluted by a bad coffee business and an over-levered, complex M&A-and-split saga that the market would rather avoid. Sell-side is split — recent fresh initiations range from Bernstein’s “Outperform” to HSBC’s deal-driven downgrade to “Hold.” The stock’s five years of dead money have trained investors to treat it as a value trap with a yield.

Strongest bull case. This is the cheapest way to own Dr Pepper — an elite, share-gaining, 28%-margin franchise that out-executes Pepsi’s cola — at ~12x EBITDA, with a 2027 catalyst (the split) that should re-rate the beverage half toward KO/PEP multiples and let the coffee half find its own (lower) clearing price. Coffee costs are set to ease in H2-2026 and could be a 2027 tailwind; the JAB overhang is gone; you are paid ~3% to wait; and the reverse-DCF says the market is pricing stagnation in a business that has compounded revenue ~7%.

Strongest bear case. This is financial engineering dressed as strategy: management levered up ~4.5x to buy a structurally-declining coffee business at a full price from a related party (JAB), inserted a $4.5B senior preferred ahead of common, and is betting that splitting the pieces creates value the SOTP says is already in the price. If coffee margins keep eroding, the soda category takes a GLP-1 volume hit, or the split slips/disappoints, you own an over-levered conglomerate with a new, unproven team and no balance-sheet cushion — and the “cheap” multiple stays cheap or de-rates further.

The 3–5 assumptions that matter most:

1. Does the split actually complete cleanly in early 2027, and does Beverage Co. list at a premium multiple? (The entire re-rating thesis.)
2. Do U.S. Coffee + JDE Peet’s margins stabilize as green-coffee costs ease in H2-2026/2027 — or is the decline structural?
3. Does the beverage business keep gaining CSD share and growing energy despite GLP-1/health pressure?
4. Does FCF hold up enough to deleverage ~0.5x/year without cutting the dividend or starving reinvestment?
5. Is the SOTP discount real, or is the equity already fairly priced (the variant question on which the whole call turns)?

What would falsify each side: Bull falsified if coffee margins keep falling into 2027 after costs ease (proving structural, not cyclical), or the split is delayed/abandoned. Bear falsified if Beverage Co. lists at ≥18x earnings while coffee finds a stable buyer/multiple and leverage drops on schedule — unlocking the SOTP and re-rating the whole.

Factor-positioning read. KDP is, in factor space, exactly what it appears: a low-beta (~0.18–0.46), DividendYield (+0.19) / LowVol (+0.23) / Consumer-Staples (+0.65) name with a slight anti-Growth tilt and NO momentum loading. It is highly idiosyncratic (R² ~0.32, specific vol 24.5%) and has been dead money for five years (y5 annualized ~0%, Sharpe −0.09), but it is no longer a falling knife — the +24% six-month bounce (m3 annualized +85%) off the $24.87 trough marks a value/special-situation recovery, not a momentum melt-up. Factor twins are MDLZ, PEP, KO, MKC, and staples ETFs. The positioning supports the variant read: consensus is offsides not on direction but on magnitude — it prices a quality beverage franchise as a stagnant value trap, when a clean split could force a re-rating. This is a quintessential abandoned-income-value-with-a-catalyst setup, with the caveat that the SOTP math keeps the upside honest.

11. Fact vs. Interpretation Table

12. Open Questions

1. Split mechanics & timing: Will the early-2027 separation be a tax-free spin, and at what relative leverage split? Any risk it gets delayed past 2027 or restructured?
2. JDE Peet’s standalone economics: What are JDE Peet’s actual margins, growth, and FCF as KDP will report them (separate segment from Q2-2026)? Are the ~$400M synergies cost-only, and credibly phased?
3. Coffee: cyclical or structural? Does U.S. Coffee margin recover in H2-2026/2027 as green-coffee costs ease, or keep falling — distinguishing a commodity cycle from structural pod erosion?
4. The preferred: Exact conversion terms, dividend mechanics (“greater of ~$53M/quarter or ~8% of earnings”), and how the $4.5B Apollo convert and $4B coffee-JV minority split between the two future companies.
5. Capital allocation post-split: What capital-return policy will Beverage Co. adopt as a standalone (buybacks? higher payout?), and what does “non-core asset divestitures to accelerate deleveraging” actually include?
6. GLP-1 trajectory: How fast does the sugary-soda volume headwind build, and does KDP’s zero-sugar/energy/hydration mix outrun it?

13. What Must Be True

Bull case — what must be true:

• The split completes cleanly (early 2027) and Beverage Co. lists at a KO/PEP-adjacent premium multiple (~16–20x earnings) on its 28%-margin, share-gaining franchise.
• U.S. Coffee + JDE Peet’s margins stabilize and recover as green-coffee costs ease (H2-2026 into 2027), so Coffee Co. clears at a defensible (if low) multiple rather than de-rating.
• The beverage business keeps gaining CSD share and scaling energy (>$1B and growing), outrunning GLP-1 pressure.
• FCF (~$2.5B FY26, growing) supports ~0.5x/year deleveraging without a dividend cut.
• Falsification test: if, 12–18 months out, coffee margins are still falling after costs ease, or the split has slipped/been abandoned, the bull case is broken.

Bear case — what must be true:

• The conglomerate discount is illusory — the SOTP shows the equity already fairly priced, and pure-play multiples disappoint.
• Coffee decline proves structural (pod commoditization, not just a cost cycle), and JDE Peet’s integration underdelivers on thin synergies.
• ~4.5x leverage + the senior preferred constrain capital returns and reinvestment; a soda-volume air-pocket (GLP-1, SNAP, taxes) hits at the wrong time.
• Falsification test: if Beverage Co. lists at ≥18x earnings, coffee margins inflect up, and leverage falls on schedule, the bear case is broken and the SOTP unlocks.

14. Conclusion

Keurig Dr Pepper is a high-quality beverage franchise — anchored by Dr Pepper, one of the few brands gaining share against Coca-Cola and PepsiCo — trapped inside a more complicated story: a fading single-serve coffee business that management has just doubled down on via a full-priced, debt-doubling acquisition, expressly in order to split the company into two pure-plays by early 2027. The stock is the rare cheap staple, priced for stagnation it has not demonstrated; but our own sum-of-the-parts says the equity already sits near the middle of its fair-value band, so the “cheapness” is more nuanced than the screens suggest. The investment is a levered, low-beta option on a self-help separation — paid to wait via a ~3% dividend, with the asymmetry turning genuinely attractive only on weakness. The thesis lives or dies on split execution, coffee-margin stabilization, and deleveraging; the body above takes no position, and the labeled Claude’s Take at the top carries the only view.

15. Source Appendix

See KDP_source_appendix.md (Appendix B in the combined report) for the full primary-source list with URLs and access dates.

APPENDIX A — Standard Diligence Questionnaire

As-of 2026-06-20. Supplemental to the research memo. Fact/Interpretation/Assumption labels applied where material.

General

What thoughtful questions have other investors asked about this company? The dominant ones: (1) Is the JDE Peet’s acquisition + split value-creating or financial engineering? (2) Will Beverage Co. command a premium pure-play multiple? (3) Is the U.S. Coffee margin decline cyclical (green-coffee costs) or structural (pod commoditization)? (4) Is the conglomerate trading at a real discount to sum-of-the-parts, or is the discount already arbitraged away? (5) Can KDP deleverage ~4.5x without cutting the dividend? (6) How fast does GLP-1 erode sugary-soda volume? (Interpretation, from sell-side notes and the Q1-2026 call.)

Cyclicality & Earnings Nature

Cyclical high or low? Mid-cycle for beverages; coffee profitability is at a cyclical low (green-coffee cost super-spike + tariffs squeezing margins, expected to ease H2-2026). (Interpretation.) External environment or internal actions? Both — internal share gains/pricing drive beverages; external commodity costs drive coffee margin swings; below-the-line GAAP volatility is mark-to-market noise. (Fact.) Revenue stability? High — overwhelmingly consumable staples (soda, water, energy, coffee pods) bought weekly; only brewers are discretionary/cyclical and they are small/declining. (Fact.) Product/service outlook? Beverages strong (CSD share gains, energy ramp, zero-sugar); coffee challenged but with self-help (Keurig Alta, premium innovation). (Interpretation.) Market size & direction? BevCo addresses a ~$300B North American refreshment market; Coffee Co a ~$400B global coffee market — both large, low-to-mid-single-digit growth, global. (Fact, per management.)

Business Quality & Competitive Moat

Industry more or less competitive? CSD is a stable, rational oligopoly (KO/PEP/KDP); coffee is getting more competitive (pod commoditization); energy is competitive and growing. (Interpretation.) Profitability (ROIC/ROE)? Consolidated ROIC ~6.9% (goodwill-depressed); cash/tangible ROIC >40%; ROE 30–80% (leverage artifact). (Fact / Interpretation.) Industry profitability, competitors, barriers? High in CSD (few competitors, brand/DSD barriers); eroding in coffee (low barriers post-patent). (Interpretation.) Easily understood? Yes — branded beverages + razor/blade coffee. (Fact.) Foreign low-cost-labor risk? Low — local manufacturing/DSD; the risk is commodity inputs, not labor arbitrage. (Fact.) Do brands matter? Decisively — Dr Pepper’s non-replicable flavor is the core moat; coffee brands matter less against commodity pods. (Interpretation.) Nature of competition? Brand, distribution, shelf-space, innovation, and price-pack architecture. (Fact.) Switching costs? Low for consumers (habit, not lock-in); the moat is brand preference + distribution scale, not switching costs. (Interpretation.)

Financial Condition & Balance Sheet

Assets not on the balance sheet? The Dr Pepper brand’s true economic value far exceeds carried intangibles; the DSD-incubation flywheel is unrecognized. (Interpretation.) Off-balance-sheet liabilities? GHOST minority-buyout obligation (~2028); supplier-finance/payables programs (historically material to OCF); operating leases. (Fact.) Accounting conservatism? Mixed — clean/small SBC (~0.6% of sales) is conservative; the 2020–22 payables-stretch that inflated then reversed OCF, and reliance on adjusted EPS, are QoE demerits. (Interpretation.) CapEx-hungry? Moderate — capex ~3–4% of sales ($486–622M), rising for cold-fill/coffee capacity; asset-lighter than a pure bottler. (Fact.)

Capital Allocation & Management

FCF generation & use? ~$1.5–2.0B steady-state legacy FCF (~$2.5B aggregate FY26 with JDE Peet’s); now prioritized to debt paydown and the dividend; buybacks suspended. (Fact.) Recent acquisitions? JDE Peet’s (~$22.5B EV, closed 4/1/2026 — transformational); GHOST (60%, 2025); plus C4, La Colombe, Electrolit, Bloom, Atypique distribution/bolt-ons. (Fact.) Buying back shares? No — suspended to fund deleveraging. (Fact.) Issuing shares to insiders? Minimal — SBC ~$97M; no large insider issuance. (Fact.) Comp policy? STIP = Net Sales 30% / Adj. Operating Income 50% / FCF 20% (size metrics, no ROIC); PSUs (added 2025) = sales growth + adj. EPS growth. CEO Cofer 2025 ~$8.2M. Say-on-pay ~96% (2026). (Fact / Interpretation: Marathon-style size mis-incentive.) Management motivations? Heavy mandatory ownership aligns them; but incentives reward size, and they just doubled the balance sheet. New, unproven-together C-suite. (Interpretation.)

Valuation & Market Data

ADR/MLP/K-1? No — a U.S. C-corp common stock (NASDAQ: KDP). (Fact.) Dividend policy? ~$1.00/share, ~3.0% yield, ~60% payout, grown annually; maintained through deleveraging. (Fact.) Profitability? 22% operating margin, ~12.5% net margin, >40% tangible-capital return — a high-quality operator. (Fact.) Net income vs. cash from operations diverging? Yes, episodically — GAAP NI swings on MtM/impairments; OCF whipsawed on the payables-stretch reversal (FY23 OCF 0.61x NI). Normalize both. (Fact.)

Risks & Downside

What would cause the stock to decline? Split delay/abandonment; coffee margins staying depressed; a soda-volume air-pocket (GLP-1/SNAP/taxes); leverage/financing strain; integration disappointment; the SOTP discount proving illusory. (Interpretation.) Catastrophic-loss risk? Low — defensive staple cash flows, IG balance sheet, hard brand assets. (Interpretation.) Total-loss risk? Remote. (Interpretation.)

Recent News & Events

Environment changed recently? Dramatically — JDE Peet’s closed (4/1/2026); split targeted early 2027; JAB fully exited (6/11/2026); new CFO (11/2025); coffee-cost super-spike. (Fact.) Significant acquisitions? JDE Peet’s (the largest in company history). (Fact.) Accounting-policy changes? Adopted a new three-segment reporting structure (U.S. Refreshment Beverages / U.S. Coffee / International) in 2025; JDE Peet’s to be reported as a separate segment until separation. (Fact.) Recent changes — markets, facilities, management? Near-total C-suite refresh; global coffee expansion via JDE Peet’s; energy portfolio scaled past $1B; Suntory Europe partnership shifted to a capital-light concentrate model. (Fact.)

APPENDIX B — Source Appendix

Research as-of 2026-06-20. Primary sources first. Quantitative figures reconciled to SEC filings; third-party aggregated data (ROIC.ai, AZI, FactorsToday) used for ratios/percentiles/factor loadings and cross-checked.

Primary — SEC Filings (CIK 0001418135)

1. Form 10-K, FY2025 (filed 2026-02-24, period 2025-12-31) — segment data (new 3-segment structure), revenue/margins, balance sheet, impairments, goodwill/intangibles, debt. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001418135&type=10-K
2. Form 10-K, FY2024 (2025-02-25) — $718M impairment, prior segment structure, payables/supplier-finance disclosure.
3. Form 10-K, FY2023 (2024-02-22) — OCF reversal (AP −$1,618M), supplier-finance program detail.
4. Form 10-K, FY2022 & FY2021 (2023-02-23; 2022-02-24) — $489M FY22 impairment, payables-stretch peak (AP +$903M).
5. Form 10-Q, Q1 2026 (filed 2026-04-23, period 2026-03-31) — Q1 results, JDE Peet’s financing structure, leverage.
6. Form 8-K filings (2025–2026) — JDE Peet’s acquisition announcement (25-Aug-2025) + split announcement, deal close (1-Apr-2026), financing/preferred terms, earnings releases.
7. DEF 14A proxy (2026-04-24; prior years 2025/2024/2023) — executive compensation metrics (STIP/LTIP/PSU design), ownership, say-on-pay.
8. Form 4 corpus (2021–2026) — insider transactions (routine grant/vest/withhold; zero open-market purchases).
9. Schedule 13D/G & block-trade filings — JAB Holdings selldown 2018→2026 (full exit 11-Jun-2026).

Primary — Company Materials

10. KDP Q1 2026 Earnings Call transcript (2026-04-23) — Tim Cofer (CEO) / Anthony DiSilvestro (CFO): FY2026 guidance, split timing (operational readiness end-2026, separation early 2027), BevCo/Coffee Co framing, ~$400M synergies, leverage ~4.5x midyear, ~$2.5B FCF, segment phasing, coffee cost commentary. (ROIC.ai transcript tool.)
11. KDP Q1 2026 earnings press release & slides (2026-04-23).
12. KDP Investor Relations — segment disclosures, brand portfolio, capital structure. https://investors.keurigdrpepper.com

Secondary — Industry & Market Data

13. Beverage Digest — U.S. CSD share data (Dr Pepper #2 single trademark by volume, 2023–24).
14. Bernstein — KDP initiation, “Outperform” (12-Jun-2026).
15. HSBC — KDP downgrade to “Hold,” PT $42→$30 on the JDE Peet’s deal (Aug-2025).
16. General financial media (Reuters/Bloomberg/WSJ) — JDE Peet’s deal terms (~€31.85/sh, ~$18.4B equity / ~$22.5B EV), JAB exit, split rationale.

Quantitative Data Providers (third-party, reconciled to filings)

17. ROIC.ai MCP — income statement, balance sheet, cash flow, profitability/credit ratios, enterprise value (~$53.2B YE25), valuation multiples (EV/EBITDA ~12x, P/E ~18x trailing). FY2020–2025.
18. AZI — own-history valuation percentiles (composite 36.6th, P/E 46.7th, P/B 36.8th, P/S 26.2nd; 6/18/2026); 5-year adjusted price CSV (price arc, 52-wk range $24.87–$34.30); news feed (JAB exit, Bernstein initiation).
19. FactorsToday — factor loadings (beta ~0.18–0.46, LowVol +0.23, DividendYield +0.19, Staples +0.65, anti-Growth, no momentum); leaderboard (y5 ~0%, m6 +24%, maxDD −31%); related stocks (MDLZ/PEP/KO/MKC); specific vol 24.5%, R² ~0.32.

Public Peer Comparables

20. Public filings and market data for beverage/staples peers (Coca-Cola, PepsiCo, Monster Beverage, Mondelez, Kimberly-Clark, Procter & Gamble) used for comparative valuation and category context.